Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
B 2.96 -3.27% -0.10
HRTX closed down 3.27 percent on Monday, March 18, 2024, on 61 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
New 52 Week Closing High Bullish -3.27%
New Uptrend Bullish -3.27%
Pocket Pivot Bullish Swing Setup -3.27%
Calm After Storm Range Contraction -3.27%
NR7 Range Contraction -3.27%
Stochastic Reached Overbought Strength -3.27%
Upper Bollinger Band Walk Strength -3.27%
Inside Day Range Contraction -3.27%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 13 hours ago
2x Volume Pace about 15 hours ago
1.5x Volume Pace about 15 hours ago
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Heron Therapeutics, Inc. Description

Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Cancer Treatment Oncology Chemotherapy Antineoplastic Drugs Occupational Safety And Health Drug Delivery Nausea

Is HRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.22
52 Week Low 0.5
Average Volume 3,343,283
200-Day Moving Average 1.57
50-Day Moving Average 2.50
20-Day Moving Average 2.69
10-Day Moving Average 2.71
Average True Range 0.23
RSI (14) 61.39
ADX 25.53
+DI 28.16
-DI 15.53
Chandelier Exit (Long, 3 ATRs) 2.52
Chandelier Exit (Short, 3 ATRs) 3.00
Upper Bollinger Bands 3.09
Lower Bollinger Band 2.29
Percent B (%b) 0.84
BandWidth 29.63
MACD Line 0.12
MACD Signal Line 0.09
MACD Histogram 0.033
Fundamentals Value
Market Cap 444.22 Million
Num Shares 150 Million
EPS -0.88
Price-to-Earnings (P/E) Ratio -3.36
Price-to-Sales 2.97
Price-to-Book 12.60
PEG Ratio -0.18
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.20
Resistance 3 (R3) 3.21 3.15 3.16
Resistance 2 (R2) 3.15 3.09 3.14 3.15
Resistance 1 (R1) 3.05 3.05 3.02 3.04 3.13
Pivot Point 2.99 2.99 2.97 2.98 2.99
Support 1 (S1) 2.89 2.93 2.86 2.88 2.79
Support 2 (S2) 2.83 2.89 2.82 2.77
Support 3 (S3) 2.73 2.83 2.76
Support 4 (S4) 2.72